Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company’s control are considered redeemable noncontrolling interests.

During the first quarter of 2026, the Company recognized redeemable noncontrolling interests of $25 million related to the acquisition of PRISM Vision and $700 million related to its acquisition of Core Ventures. The Company utilized the Monte Carlo simulation model to determine the fair value of the redeemable noncontrolling interests for both acquisitions.

Redeemable noncontrolling interests are presented outside of stockholders’ deficit in the Company’s Condensed Consolidated Balance Sheet. Refer to Financial Note 2, “Business Acquisitions and Divestitures,” for additional information on the acquisition activity discussed above.

Net income attributable to noncontrolling interests includes third-party equity interests in the Company’s consolidated entities, including ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC and SCRI Oncology, LLC.

The Company allocated $47 million and $45 million of net income to noncontrolling interests during the three months ended June 30, 2025 and 2024, respectively, which was recorded in “Net income attributable to noncontrolling interests” in the Company’s Condensed Consolidated Statements of Operations.

Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2025 and 2024, were as follows:


(In millions)	Noncontrolling Interests		Redeemable Noncontrolling Interests
Balance, March 31, 2025	$	380	$	—
Net income attributable to noncontrolling interests	47		—

Payments to noncontrolling interests	(47)		—

Acquisition of PRISM Vision	—		25
Acquisition of Core Ventures	—		700
Other	(1)		—
Balance, June 30, 2025	$	379	$	725


(In millions)	Noncontrolling Interests		Redeemable Noncontrolling Interests
Balance, March 31, 2024	$	372	$	—
Net income attributable to noncontrolling interests	45		—
Payments to noncontrolling interests	(43)		—
Other	—		—
Balance, June 30, 2024	$	374	$	—